Tetracaine Hydrochloride Ophthalmic Solution Recalled for Temperature Abuse
McKesson Medical-Surgical is recalling Tetracaine Hydrochloride Ophthalmic Solution due to cGMP deviations from temperature abuse. The recall affects 43 cartons distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall involves a manufacturing quality issue (cGMP deviations related to temperature control) with no reported illnesses, injuries, or adverse events. The recall is precautionary in nature.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Tetracaine Hydrochloride Ophthalmic Solution, 0.5%, 4 mL bottles (NDC 0065-0741-14), manufactured by Alcon Surgical Inc. The recall affects 43 cartons of 12 blister packs that were distributed nationwide across the United States.
The recall is due to cGMP deviations involving temperature abuse. McKesson Medical-Surgical was unable to identify the particular lot numbers for each customer and has provided individual notification letters to affected customers listing the distribution dates and the dates the impacted product may have been shipped to them.
Healthcare providers and patients who received this product should verify whether their supply is affected based on the distribution dates provided in their notification letter. Patients should consult their healthcare provider regarding use of any recalled product.
The recalled product
- Product
- TETRACAINE HYDROCHLORIDE (TETRACAINE HYDROCHLORIDE)
- Brand
- TETRACAINE HYDROCHLORIDE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Ophthalmic Anesthetic
- Hazard
- temperature-abuse
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 0300650741149
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27